COVID-SEROKLIR

Welcome to the Brand page for “COVID-SEROKLIR”, which is offered here for Diagnostic preparations for medical purposes for use in hospitals; diagnostic agents, preparations and substances for medical or veterinary purposes; medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens; assays, reagents, media, solutions, buffers and preparations for medical, clinical and diagnostic use; diagnostic agents for carrying out serologic tests for medical and clinical purposes; diagnostic reagents for serologic tests of infections for medical and clinical purposes; diagnostic agents, preparations, substances and diagnostic test kits primarily comprised of material, preparations, assays and reagents and also consisting of vessels, containers and implements for performing serological, molecular pcr, antigen and antibody detection tests, and used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; kits and components comprised of assays, reagents, media, solutions, buffers, antibodies, antigens, control materials, membranes, plasma, diagnostic chemicals, calibrators, swabs for medical purposes, plates, vessels, tubes, pipettes, trays, panels, slides, cards and bottles for use in performing medical diagnostic testing for medical or veterinary use; test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection, infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; diagnostic test in the nature of medical diagnostic reagents and assays for testing of bodily fluids for antibodies for use in disease detection, sars-cov-2, covid-19, cancer, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; medical and clinical test kits comprised of assays, reagents, media, solutions, buffers and preparations for use in disease detection and monitoring of coronavirus, sars-cov-2 and covid-19; diagnostic preparations for medical and clinical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; preparations and substances for the diagnosis, prevention and treatment of sars-cov-2, covid-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of sars-cov-2, covid-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to sars-cov-2 or covid-19;.

Its status is currently believed to be active. Its class is unavailable. “COVID-SEROKLIR” is believed to be currently owned by “Kantaro Biosciences LLC”.